Rapport Therapeutics (RAPP) Change in Account Payables (2023 - 2026)
Rapport Therapeutics (RAPP) reported Change in Account Payables of $2.3 million for Q1 2026, up 1145.95% year-over-year from $185000.0 in Q1 2025, and up 95.67% quarter-over-quarter from $1.2 million in Q4 2025.
Rapport Therapeutics (RAPP) Change in Account Payables (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Change in Account Payables data on file, last reported at $2.3 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $2.3 million, up 1145.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 345.53% YoY), and the FY2025 annual result was $2.2 million, up 740.17% from the prior year.
- Change in Account Payables climbed to $2.3 million in Q1 2026 per RAPP's latest filing, from $1.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.3 million in Q1 2026 and troughed at -$1.1 million in Q1 2024.
- A 4-year average of $502909.1 and a median of $633000.0 in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables tumbled 489.13% in 2025, then jumped 1145.95% in 2026.
- A 4-year view of Change in Account Payables shows it stood at $725000.0 in 2023, then slipped by 10.62% to $648000.0 in 2024, then surged by 81.79% to $1.2 million in 2025, then jumped by 95.67% to $2.3 million in 2026.
- Business Quant data shows RAPP's Change in Account Payables at $2.3 million in Q1 2026, $1.2 million in Q4 2025, and -$179000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -9.42 Mn |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | 2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.31 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | -179,000.00 |
| Sep 30, 2025 | -179,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 185,000.00 |
| Mar 31, 2025 | 185,000.00 |
| Dec 31, 2024 | 648,000.00 |
| Dec 31, 2024 | 648,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | -1.13 Mn |
| Mar 31, 2024 | -1.13 Mn |
| Dec 31, 2023 | 725,000.00 |
| Dec 31, 2023 | 725,000.00 |